Fundz

Libra Therapeutics Promotes Martin Gill, Ph.D. to Chief Scientific Officer

PRIVATEOct 15, 2025

Position

Chief Scientific Officer

Company

Libra Therapeutics

Martin Gill
San DiegoBiotechnologyHealth CareTherapeutics

Description

Libra Therapeutics has announced the promotion of Martin (Marty) Gill, Ph.D., to Chief Scientific Officer. Dr. Gill, who has been with the company since 2021, will continue leading research efforts aimed at developing innovative therapies for neurodegenerative diseases.

Quick answer

Libra Therapeutics Promotes Martin Gill, Ph.D. to Chief Scientific Officer (October 15, 2025). Libra Therapeutics is based in San Diego, California, United States.

Who is the new Chief Scientific Officer at Libra Therapeutics?
Libra Therapeutics named Martin Gill Chief Scientific Officer, announced October 15, 2025.
What did Libra Therapeutics announce on October 15, 2025?
Libra Therapeutics has announced the promotion of Martin (Marty) Gill, Ph.D., to Chief Scientific Officer. Dr. Gill, who has been with the company since 2021, will continue leading research efforts aimed at developing innovative therapies for neurodegenerative diseases.
What does Libra Therapeutics do?
Libra Therapeutics is a biotechnology company developing novel disease-modifying therapeutics to restore disrupted cellular balance in lysosome function and autophagy with the potential to slow the disease progression...
Where is Libra Therapeutics based?
Libra Therapeutics is based in San Diego, California, United States.
Which similar companies made leadership changes around the same time?
Fate Therapeutics (October 14, 2025), Atossa Therapeutics (October 14, 2025), Kenox Pharmaceuticals (October 21, 2025) and Cartesian Therapeutics, Inc. (October 8, 2025) also announced leadership changes within 45 days of Libra Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Libra Therapeutics, and when

A new leader at Libra Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Libra Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Libra Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Libra Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Libra Therapeutics

Location

San Diego, California, United States

About

Libra Therapeutics is a biotechnology company developing novel disease-modifying therapeutics to restore disrupted cellular balance in lysosome function and autophagy with the potential to slow the disease progression of amyotrophic lateral sclerosis, Parkinson's disease, and other neurodegenerative diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Libra Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Shawn
Likely contact at this company
••••••••@••••••••

See Shawn's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Libra Therapeutics's next move

Learn about Strategic plan

Libra Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.